Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0003-4975(98)00633-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: Diagnostic and therapeutic challenges of fungal endocarditis by in a child with congenital heart defects.
Front Pediatr
October 2023
Pediatric Intensive Care Residence Program, Pontifical Catholic University of Campinas Hospital, Campinas, Brazil.
Background: patients with congenital cardiopathies are the main group at risk for infective endocarditis (IE) in the pediatric population. Fungal etiology is responsible for 2%-4% of all IEs, and the genus is an increasingly prevalent cause of infections in human beings.
Case Presentation: We describe a 9-year-old male with multiple surgical procedures to correct congenital cardiopathy defects, including insertion of RV-PA conduit, who was admitted due to suspicion of pneumonia and needed a surgical approach after being diagnosed with a mycotic pseudoaneurysm in the right ventricle's outflow tract, with dilation of the RV-PA conduit.
Congenital Aortic Valve Repair When the Options aren't Good: Truncus Arteriosus and Transposition of the Great Arteries.
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu
February 2023
Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Department of Cardiothoracic Surgery, The Royal Melbourne Hospital, Melbourne,Victoria, Australia.
Patients with truncus arteriosus and transposition of great arteries are prone to neo-aortic valve insufficiency. Although presenting at opposite ends of the age spectrum, both conditions tend to be commonly associated with neo aortic root dilatation. In patients with truncus arteriosus there is an additional complexity of quadricuspid valve morphology, which make up the majority of valves requiring repair.
View Article and Find Full Text PDFFibroblast growth factor 2 inhibits myofibroblastic activation of valvular interstitial cells.
PLoS One
June 2022
Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Grafton, New Zealand.
Heart valve disease is a growing problem worldwide. Though very common in older adults, the mechanisms behind the development of the disease aren't well understood, and at present the only therapeutic option is valve replacement. Valvular interstitial cells (VICs) may hold the answer.
View Article and Find Full Text PDFDetecting sub-clinical disease activity in patients with chronic rheumatic valvular heart disease.
Indian Heart J
October 2021
Department of Cardiology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Electronic address:
Objective: Valve disease progression in rheumatic heart disease(RHD) is generally attributed to recurrent attacks of acute rheumatic fever(ARF). However, persistence of chronic sub-clinical inflammation remains a plausible but unproven cause. Non-invasive means to identify sub-clinical inflammation may facilitate research efforts towards understanding its contribution to disease progression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!